Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

AstraZeneca: CHMP Recommends Enhertu For Approval In The EU

(RTTNews) - AstraZeneca (AZN, AZN.L, ZEG.DE, AZN.ST) and Daiichi Sankyo's (4568.T) Enhertu has been recommended for approval in the European Union by CHMP as a monotherapy for the adjuvant treatment of adult patients with resected HER2-positive breast cancer who have residual inv

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Health & Medicine

More from Monday 21 September →